 |
 |
 |
Investor RelationsTheraCarb is currently offering investors an early opportunity to become involved with a promising young Canadian biotechnology company. We recognize the talent of our team and the strength of our science. The credible alliances we have entered into are a testament to TheraCarb’s potential. We will continue to take our research and preclinical candidates as far as we can. With future opportunities for an acquisition or a transition to the public markets, early stage investors can maximize their potential from the numerous value lifts that can only be found with an early biotechnology company like TheraCarb. For more information, please contact: Dr. Murray Ratcliffe, COO |